Anticoccidial efficacy and chicken toleration of potent new polyether ionophores. 1. The septamycin relative

Related Experiment Videos

A P Ricketts1, J P Dirlam, J E Shively

  • 1Central Research Division, Pfizer Inc, Groton, Connecticut 06340.

Poultry Science
|October 1, 1992
PubMed

Insights

The anticoccidial drug CP-82,009 effectively controls Eimeria in poultry, showing broad-spectrum efficacy and no adverse effects on growth or feed efficiency in chickens.

Area of Science:

  • Veterinary Parasitology
  • Poultry Science
  • Drug Discovery

Background:

  • Coccidiosis is a significant parasitic disease in poultry, caused by Eimeria species.
  • Ionophores are commonly used to control coccidiosis in chickens.
  • There is a continuous need for novel anticoccidial agents with high efficacy and safety.

Purpose of the Study:

  • To evaluate the anticoccidial activity of the novel ionophore CP-82,009.
  • To assess the efficacy of CP-82,009 against major poultry Eimeria species.
  • To determine the safety and impact of CP-82,009 on broiler chicken growth and feed efficiency.

Main Methods:

  • Laboratory battery trials were conducted to assess anticoccidial efficacy.
  • Efficacy was measured by lesion control and weight suppression.
  • Growth rate and feed efficiency were evaluated in uninfected broiler chickens over 21-day (battery) and 49-day (floor pen) periods.

Main Results:

  • CP-82,009 demonstrated broad-spectrum anticoccidial efficacy at 4 and 5 ppm, comparable to commercial ionophores.
  • The drug effectively controlled lesions and weight suppression caused by Eimeria.
  • No negative impact on growth rate or feed efficiency was observed in chickens treated with CP-82,009.

Conclusions:

  • CP-82,009 is a highly efficacious anticoccidial agent against poultry Eimeria.
  • The compound is well-tolerated by broiler chickens at efficacious doses.
  • CP-82,009 represents a potent new option among anticoccidial ionophores.

Related Concept Videos